Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
Diabetes drug blunts exercise-induced health improvements
A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease:…
Research shows citrus and grape compounds may protect against type 2 diabetes
Nov 2 2025 A new Italian study reveals that a daily blend of citrus and grape extracts with…
Which foods and supplements really ease chronic constipation?
Backed by four major reviews, the BDA’s first-ever constipation guidelines separate science from myth, highlighting psyllium, kiwifruit, and…
New research aims to use eyedrops to lower lifetime risk of nearsightedness complications
For the first time, researchers are leading a national study to see if the onset of nearsightedness can…
Carrot fiber supplement boosts gut bacteria and immune defenses
In just four weeks, a daily 500 mg dose of carrot-derived fiber enriched beneficial Bifidobacteria, firmed stools, and…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
In-hospital start of dapagliflozin shows no significant short-term benefit in heart failure patients
In-hospital initiation of dapagliflozin did not significantly reduce the short-term risk of cardiovascular death or worsening heart failure…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial
Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Babies fed blueberries show fewer allergy symptoms and boosted immune balance
Feeding blueberries to infants in the first year of life may help alleviate allergy symptoms and alter immune…